Agile Therapeutics Inc (AGRX) is near the top in its industry group according to InvestorsObserver. AGRX gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Agile Therapeutics Inc gets a 89 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 136 out of 148 industries.
AGRX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on AGRX!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Agile Therapeutics Inc Stock Today?
Agile Therapeutics Inc (AGRX) stock is down -6.32% while the S&P 500 has gained 0.28% as of 2:35 PM on Friday, Mar 24. AGRX is lower by -$0.02 from the previous closing price of $0.24 on volume of 666,668 shares. Over the past year the S&P 500 is down -12.40% while AGRX is lower by -97.91%. AGRX lost -$14.93 per share the over the last 12 months.
Click Here to get the full Stock Report for Agile Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
